Skip to main content
OpenTrials

Clinical trial condition

Hepatitis C, Chronic

Explore clinical trials studying Hepatitis C, Chronic. Study availability and eligibility vary by location and protocol.

699 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis C, Chronic trial results

Completed

The Patient-Reported Outcomes Project of HCV-TARGET

NCT02601820

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • University of California at Davis Davis, California, United States
  • Yale University New Haven, Connecticut, United States
  • University of Florida Gainesville, Florida, United States
  • Rush University Chicago, Illinois, United States
View Trial Details
Completed

A Study to Investigate the Safety, Pharmacokinetics, and Efficacy of Combination Treatment of AL-335, Odalasvir, and Simeprevir in Japanese Participants With Chronic Hepatitis C Genotype 1 or 2 Virus Infection, With or Without Compensated Cirrhosis Who Are Direct Acting Antiviral Treatment-naive

NCT02993250

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Amagasaki-shi, Japan
  • Bunkyō City, Japan
  • Hiroshima, Japan
  • Kagoshima, Japan
View all 14 locations
View Trial Details
Completed

Efficacy and Safety of 8-weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve Adults With HCV Genotype 1-6 and Aspartate Aminotransferase to Platelet Ratio Index (APRI) ≤1

NCT03212521

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations
  • Parkway Medical Center /ID# 161261 Birmingham, Alabama, United States
  • Arkansas Gastroenterology /ID# 161266 North Little Rock, Arkansas, United States
  • UC Davis Medical Center /ID# 161138 Sacramento, California, United States
  • Yale University /ID# 161258 New Haven, Connecticut, United States
View all 42 locations
View Trial Details
Completed

A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of the Combination of AL-335, Odalasvir, and Simeprevir

NCT02569710

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • CAP Research Ltd Phoenix, Mauritius
  • Republican Clinical Hospital Chisinau, Moldova
  • Auckland Clinical Studies Auckland, New Zealand
  • Christchurch Clinical Studies Trust Christchurch, New Zealand
View Trial Details
Completed

KW-136 With Sofosbuvir for Chinese Adults With Chronic Hepatitis C

NCT03995485

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Chinese PLA 302 Hospital Beijing, Beijing Municipality, China
  • Capital Medical University Affiliated Beijing Youyi Hospital Beijing, Beijing Municipality, China
  • Capital Medical University Affiliated Beijing You'an Hospital Beijing, Beijing Municipality, China
  • Capital Medical University Affiliated Beijing Ditan Hospital Beijing, Beijing Municipality, China
View all 19 locations
View Trial Details

Related conditions